课题基金 / 基金详情

NO Inhibition in Systemic/Renal Hemodynamics in Patients with Cirrhosis

NO Inhibition in Systemic/Renal Hemodynamics in Patients with Cirrhosis
NO 对肝硬化患者全身/肾脏血流动力学的抑制
批准号：
7043349
负责人：
Nezam Hassan Afdahl
金额：
$0.52万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2003
资助国家：
美国
项目状态：
已结题
起止时间：
2003-12-01 至 2004-11-30
来源：
https://reporter.nih.gov/project-details/7043349
关键词：
adult human (21+)ascitescardiovascular pharmacologyclinical researchdrug screening /evaluationendocrine pharmacologyenzyme inhibitorshemodynamicshormone regulation /control mechanismhuman subjecthuman therapy evaluationkidney circulationkidney functionkidney pharmacologyliver cirrhosisliver disorder chemotherapynitric oxidepatient oriented research

项目成果

Nezam Hassan Afdahl的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
CLINICAL TRIAL: PHASE I STUDY OF SILYMARIN IN CHRONIC HEPATITIS C OR FATTY LIVER
PHASE I STUDY OF SILYMARIN IN CHRONIC HEPATITIS C OR FATTY LIVER DISEASE
Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
海外基金